Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company was set up on Wednesday the 16th of June 1976. Their current partial address is Dublin, and the company status is Normal. The company's current directors have been the director of 1 other Irish company between them. Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company has 1 shareholder. This Irish company shares its Eircode with at least 193 other companies.
| Company Name: | Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company |
| Company Status: | NORMAL |
| Company Address: | 6th Floor, South Bank House, Barrow Street Dublin 4, Dublin 4, Dublin |
| Telephone: | +353 (0)1 609 7100 |
| Website: | www.astrazeneca.com |
| Key Executive: | Mr O'Reilly |
| Company Size: | Log-In To View |
| Disclaimer | Other Details |
|---|---|
| Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us. | |
Mr O'Reilly is a Company Director of Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company since 2019
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
The latest documents filed with the Companies Registration Office for Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| Form B1C - Annual Return General | 30/09/2023 | 04/10/2023 | Join Up | |
| FINANCIAL STATEMENT | 30/09/2023 | 04/10/2023 | Join Up | |
| OTHER DIRECTORSHIP LIST | 30/09/2023 | 04/10/2023 | Join Up | |
| B10 CHANGE IN DIRECTORS/SECRETARY | 19/07/2023 | 20/07/2023 | Join Up | |
| Form B1C - Annual Return General | 05/09/2022 | 20/09/2022 | Join Up | |
| THIS COMPANY HAS 150 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
View the Latest Credit Report and Credit Limit on Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company.
| Company Status: | Normal |
| Latest Credit Movement: |  |
| Date of Last Movement: | 06/10/2023 |
| Latest Accounts Filed: | 04/10/2023 |
| Report Based on Accounts: | 31/12/2022 |
| Next Set of Accounts Due: | 30/09/2024 |
| Overdue: | No |
| Credit Score: | Join-Up to View |
To View the latest Credit Rating or Credit Limit on Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Satisfy due diligence requirements on Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company and Anti-Money Laundering checks (AML checks) on Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company
| Company Type: | DAC - Designated Activity Company (Limited By Shares) |
| Number of Shareholders: | 1 |
Log-in now to run Due Diligence checks and Compliance checks on Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
More people choose Vision-net over any other search service... ask us why?
28/11/2023
We all could use more time in the day to focus on our value-adding tasks, but manual admin, data analysis and decision making takes time, and for good reason.
01/11/2023
Earlier this year the Central Bank of Ireland (CBI) enacted the Individual Accountability Framework (IAF) with the aim of promoting an improved governance system and positive cultural change in Regulated Financial Service Providers (RFSPs).
20/10/2023
Examining the third quarter of this year against last year presents a peculiar picture.
16/10/2023
A 12% year-on-year increase in the number of company start-ups was recorded for the third quarter of 2023, with 185 insolvencies recorded in Q3 this year.
